Nature Biotechnology
Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
Nature Biotechnology, Published online: 30 June 2022; doi:10.1038/s41587-022-01377-0Aneuploidy and chromosomal truncations are frequent outcomes of CRISPR–Cas9 editing in human T cells.